Skip to main content
Clinical Trials/NCT05909982
NCT05909982
Completed
Phase 1

Effect of Ischemic Post-conditioning on Infarct Volume in Patients With Acute Ischemic Stroke After Mechanical Thrombectomy

Capital Medical University1 site in 1 country20 target enrollmentApril 1, 2023

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Acute Ischemic Stroke
Sponsor
Capital Medical University
Enrollment
20
Locations
1
Primary Endpoint
Infarct volume
Status
Completed
Last Updated
last year

Overview

Brief Summary

Ischemic post-conditioning is a neuroprotective strategy attenuating reperfusion injury in animal stroke models. The investigators have conducted a 3 + 3 dose-escalation trial to demonstrate the safety and tolerability of ischemic post-conditioning incrementally for a longer duration of up to 5 min × 4 cycles in stroke patients undergoing mechanical thrombectomy. This study aims to assess the infarct volume after ischemic post-conditioning in patients with acute ischemic stroke who are treated with mechanical thrombectomy.

Registry
clinicaltrials.gov
Start Date
April 1, 2023
End Date
January 28, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Capital Medical University
Responsible Party
Principal Investigator
Principal Investigator

Ji Xunming,MD,PhD

Professor

Capital Medical University

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years;
  • Acute ischemic stroke within 24 hours from stroke onset (or from time last known well) to groin puncture;
  • Previous mRS ≤ 2;
  • Baseline NIHSS ≥ 6;
  • Baseline ASPECTS ≥ 6;
  • With an occlusion of unilateral middle cerebral artery M1 segment/distal intracranial carotid artery;
  • Successful recanalization (mTICI ≥ 2b) after thrombectomy confirmed by DSA;
  • Written informed consent provided by the patients or their legal relatives.

Exclusion Criteria

  • Confirmed or clinically suspected cerebral vasculitis/fibromuscular dysplasia;
  • Difficulty in reaching the designated position of the balloon used for ischemic post-conditioning;
  • Stenting in the middle cerebral artery M1 segment/distal intracranial carotid artery during thrombectomy;
  • \> 2 times balloon dilations as rescue therapy due to angioplasty during thrombectomy;
  • Moderate/severe residual stenosis (≥ 50%) in the offending artery after thrombectomy;
  • Patients with contraindications to MRI;
  • Other conditions that the investigator considered inappropriate for inclusion.

Outcomes

Primary Outcomes

Infarct volume

Time Frame: 72 hours after procedure

Infarct volume at 72 hours after procedure

Secondary Outcomes

  • The progression of infarct volume(Baseline and 72 hours after procedure)
  • The proportion of functional independence at 90 days(90 days after procedure)
  • The distribution of the mRS score at 90 days(90 days after procedure)
  • The proportion of early neurological improvement(24 hours after procedure)
  • Recanalization rate(24 hours after procedure)
  • National Institute of Health Stroke Scale (NIHSS) score(24 hours after procedure)
  • The proportion of favorable outcome at 90 days(90 days after procedure)
  • NIHSS score at 7 days after procedure/discharge(7 days after procedure/discharge)
  • Hemodynamic assessment(Within 24 hours after procedure)

Study Sites (1)

Loading locations...

Similar Trials